Boyd Watterson Asset Management LLC OH Increases Stock Position in Waters Corporation $WAT

Boyd Watterson Asset Management LLC OH raised its stake in shares of Waters Corporation (NYSE:WAT) by 1,381.9% in the 1st quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The fund owned 2,371 shares of the medical instruments supplier’s stock after purchasing an additional 2,211 shares during the quarter. Boyd Watterson Asset Management LLC OH’s holdings in Waters were worth $706,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

A number of other institutional investors have also recently made changes to their positions in the stock. Fundsmith LLP raised its position in shares of Waters by 9.6% during the 3rd quarter. Fundsmith LLP now owns 3,955,498 shares of the medical instruments supplier’s stock valued at $1,185,898,000 after buying an additional 347,091 shares in the last quarter. Geode Capital Management LLC grew its position in Waters by 0.5% in the fourth quarter. Geode Capital Management LLC now owns 1,593,388 shares of the medical instruments supplier’s stock worth $602,921,000 after acquiring an additional 8,590 shares in the last quarter. Invesco Ltd. increased its stake in Waters by 32.3% in the third quarter. Invesco Ltd. now owns 1,472,419 shares of the medical instruments supplier’s stock valued at $441,446,000 after acquiring an additional 359,596 shares during the last quarter. Fundsmith Investment Services LTD. raised its position in Waters by 11.1% during the third quarter. Fundsmith Investment Services LTD. now owns 1,356,289 shares of the medical instruments supplier’s stock valued at $406,629,000 after purchasing an additional 135,504 shares in the last quarter. Finally, Veritas Asset Management LLP raised its position in Waters by 112.3% during the fourth quarter. Veritas Asset Management LLP now owns 1,241,206 shares of the medical instruments supplier’s stock valued at $471,447,000 after purchasing an additional 656,436 shares in the last quarter. Institutional investors own 94.01% of the company’s stock.

Analyst Upgrades and Downgrades

A number of equities analysts have recently issued reports on WAT shares. Robert W. Baird set a $387.00 price objective on Waters in a report on Wednesday, May 6th. Evercore raised Waters from an “in-line” rating to an “outperform” rating and set a $350.00 price objective on the stock in a report on Monday, April 6th. The Goldman Sachs Group upgraded Waters to a “strong-buy” rating in a research report on Wednesday, April 1st. Wolfe Research initiated coverage on Waters in a research note on Tuesday, June 2nd. They issued an “outperform” rating and a $425.00 target price for the company. Finally, HSBC increased their price target on shares of Waters from $415.00 to $435.00 and gave the company a “buy” rating in a research report on Wednesday, June 3rd. Four analysts have rated the stock with a Strong Buy rating, nine have assigned a Buy rating and nine have assigned a Hold rating to the company’s stock. Based on data from MarketBeat, the company currently has a consensus rating of “Moderate Buy” and an average price target of $396.68.

Waters Trading Up 0.1%

Shares of WAT stock opened at $378.62 on Friday. The stock has a market capitalization of $37.18 billion, a PE ratio of 48.11, a P/E/G ratio of 2.29 and a beta of 1.20. Waters Corporation has a 1-year low of $275.05 and a 1-year high of $414.15. The business has a 50-day moving average of $350.65 and a 200 day moving average of $346.80. The company has a debt-to-equity ratio of 0.32, a current ratio of 1.79 and a quick ratio of 1.13.

Waters (NYSE:WAT) last announced its quarterly earnings results on Tuesday, May 5th. The medical instruments supplier reported $2.70 EPS for the quarter, topping analysts’ consensus estimates of $2.31 by $0.39. Waters had a return on equity of 15.60% and a net margin of 11.91%.The business had revenue of $1.27 billion for the quarter, compared to analysts’ expectations of $1.20 billion. During the same period in the previous year, the firm earned $2.25 EPS. The business’s quarterly revenue was up 91.4% on a year-over-year basis. Waters has set its Q2 2026 guidance at 2.950-3.050 EPS and its FY 2026 guidance at 14.400-14.600 EPS. As a group, sell-side analysts anticipate that Waters Corporation will post 14.51 earnings per share for the current year.

Waters Profile

Waters Corporation is a global provider of analytical instruments, software and services for laboratory and research applications. The company designs, manufactures and sells technologies centered on liquid chromatography, mass spectrometry, separation science, and related sample preparation and detection systems. Its product portfolio includes chromatographs, mass spectrometers, columns and consumables, laboratory informatics and workflow software, as well as technical support and training services that help customers run and interpret complex analyses.

Waters serves a wide range of end markets that include pharmaceutical and biotechnology companies, contract research and testing laboratories, academic and government research institutions, clinical diagnostics, food and environmental testing, and industrial and chemical manufacturers.